Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Assets Average (2021 - 2025)

Journey Medical (DERM) has disclosed Assets Average for 5 consecutive years, with $83.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets Average rose 28.72% year-over-year to $83.2 million, compared with a TTM value of $83.2 million through Sep 2025, up 28.72%, and an annual FY2024 reading of $78.5 million, down 13.69% over the prior year.
  • Assets Average was $83.2 million for Q3 2025 at Journey Medical, roughly flat from $83.1 million in the prior quarter.
  • Across five years, Assets Average topped out at $117.2 million in Q2 2022 and bottomed at $64.6 million in Q3 2024.
  • Average Assets Average over 5 years is $86.4 million, with a median of $82.9 million recorded in 2023.
  • The sharpest move saw Assets Average tumbled 38.79% in 2023, then grew 28.72% in 2025.
  • Year by year, Assets Average stood at $93.2 million in 2021, then increased by 14.47% to $106.7 million in 2022, then tumbled by 33.07% to $71.4 million in 2023, then grew by 1.06% to $72.1 million in 2024, then increased by 15.29% to $83.2 million in 2025.
  • Business Quant data shows Assets Average for DERM at $83.2 million in Q3 2025, $83.1 million in Q2 2025, and $82.6 million in Q1 2025.